Cerebrospinal fluid test results and associations with subsequent mental disorders, neurological diseases, and CNS infections: A population-based cohort study

[1]  D. Wildgruber,et al.  Cerebrospinal fluid findings in patients with psychotic symptoms—a retrospective analysis , 2021, Scientific Reports.

[2]  M. Nordentoft,et al.  Efficacy and safety of anti-inflammatory agents in treatment of psychotic disorders – A comprehensive systematic review and meta-analysis , 2020, Brain, Behavior, and Immunity.

[3]  B. Feige,et al.  Diagnosing Organic Causes of Schizophrenia Spectrum Disorders: Findings from a One-Year Cohort of the Freiburg Diagnostic Protocol in Psychosis (FDPP) , 2020, Diagnostics.

[4]  B. Feige,et al.  Cerebrospinal fluid, antineuronal autoantibody, EEG, and MRI findings from 992 patients with schizophreniform and affective psychosis , 2020, Translational Psychiatry.

[5]  L. Petersen,et al.  Infections of the central nervous system as a risk factor for mental disorders and cognitive impairment: A nationwide register-based study , 2020, Brain, Behavior, and Immunity.

[6]  O. Mors,et al.  Efficacy of anti‐inflammatory treatment on major depressive disorder or depressive symptoms: meta‐analysis of clinical trials , 2019, Acta psychiatrica Scandinavica.

[7]  H. Nielsen,et al.  Risk of inflammatory bowel disease after Campylobacter jejuni and Campylobacter concisus infection: a population-based cohort study , 2019, Scandinavian journal of gastroenterology.

[8]  M. Nordentoft,et al.  Cerebrospinal fluid markers of inflammation and infections in schizophrenia and affective disorders: a systematic review and meta-analysis , 2018, Molecular Psychiatry.

[9]  P. Falkai,et al.  Absence of cerebrospinal fluid antineuronal antibodies in schizophrenia spectrum disorders – CORRIGENDUM , 2018, The British Journal of Psychiatry.

[10]  P. Falkai,et al.  Absence of cerebrospinal fluid antineuronal antibodies in schizophrenia spectrum disorders , 2018, British Journal of Psychiatry.

[11]  M. Brouwer,et al.  Technological advances and changing indications for lumbar puncture in neurological disorders , 2018, The Lancet Neurology.

[12]  J. Leza,et al.  The effect of excess weight on circulating inflammatory cytokines in drug-naïve first-episode psychosis individuals , 2018, Journal of Neuroinflammation.

[13]  Warren W. Kretzschmar,et al.  Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression , 2017, Nature Genetics.

[14]  A. Carvalho,et al.  Peripheral cytokine and chemokine alterations in depression: a meta‐analysis of 82 studies , 2017, Acta psychiatrica Scandinavica.

[15]  D. Goldsmith,et al.  A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression , 2016, Molecular Psychiatry.

[16]  L. Tebartz van Elst,et al.  Immunological findings in psychotic syndromes: a tertiary care hospital's CSF sample of 180 patients , 2015, Front. Hum. Neurosci..

[17]  J. Langosch,et al.  An observational study of inflammation in the central nervous system in patients with bipolar disorder , 2015, Bipolar disorders.

[18]  O. Mors,et al.  Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials. , 2014, JAMA psychiatry.

[19]  C. Spencer,et al.  Biological Insights From 108 Schizophrenia-Associated Genetic Loci , 2014, Nature.

[20]  P. Mortensen,et al.  Autoimmune diseases and severe infections as risk factors for schizophrenia: a 30-year population-based register study. , 2011, The American journal of psychiatry.

[21]  O. Mors,et al.  The Danish Psychiatric Central Research Register , 2011, Scandinavian journal of public health.

[22]  J. Hallas,et al.  The Danish National Prescription Registry , 2011, Scandinavian journal of public health.

[23]  C. Pedersen,et al.  The Danish Civil Registration System , 2011, Scandinavian journal of public health.

[24]  Elsebeth Lynge,et al.  The Danish National Patient Register , 2011, Scandinavian journal of public health.

[25]  R. Erichsen,et al.  Existing data sources for clinical epidemiology: The clinical laboratory information system (LABKA) research database at Aarhus University, Denmark , 2011, Clinical Epidemiology.

[26]  K. Kim.  Mechanisms of microbial traversal of the blood–brain barrier , 2008, Nature Reviews Microbiology.

[27]  B. Volpe,et al.  Cognition and immunity; antibody impairs memory. , 2004, Immunity.

[28]  T. Pollmächer,et al.  Oligoclonal bands and specific antibody indices in human narcolepsy , 2004 .

[29]  D. Rubinow,et al.  Cerebrospinal fluid total protein in patients with affective disorders , 1995, Psychiatry Research.

[30]  M. Ackenheil,et al.  Immunoglobulin and albumin content of cerebrospinal fluid in schizophrenic patients: Relationship to negative symptomatology , 1995, Schizophrenia Research.

[31]  D. Weinberger,et al.  Abnormal cerebrospinal fluid protein indices in schizophrenia , 1985, Biological Psychiatry.

[32]  S. Bouallègue,et al.  A New Method , 2021, Black Power and the American Myth.